JF
FULC icon

Jump Financial’s Fulcrum Therapeutics FULC Stock Holding History

Jump Financial’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
369,805
+277,605
+301% +$2.58M 0.04% 530
2025
Q4 		$1.04M Buy
+92,200
New +$938K 0.01% 956
2025
Q2 		– Sell
-10,550
Closed -$30.4K – 1915
2025
Q1 		$30.4K Buy
+10,550
New +$38.8K ﹤0.01% 1528
2024
Q3 		– Sell
-94,181
Closed -$584K – 1807
2024
Q2 		$584K Buy
94,181
+63,337
+205% +$480K 0.01% 1074
2024
Q1 		$291K Buy
+30,844
New +$275K 0.01% 1465
2023
Q4 		– Sell
-91,790
Closed -$408K – 1937
2023
Q3 		$408K Buy
+91,790
New +$401K 0.02% 1125
2022
Q3 		– Sell
-29,000
Closed -$142K – 1710
2022
Q2 		$142K Buy
+29,000
New +$283K 0.01% 1380
2022
Q1 		– Sell
-10,882
Closed -$193K – 1666
2021
Q4 		$193K Buy
+10,882
New +$216K 0.01% 1124
2021
Q3 		– Sell
-12,699
Closed -$133K – 1219
2021
Q2 		$133K Buy
+12,699
New +$128K 0.01% 949

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Jump Financial's FULC Position: Q1 2026 in Review

Jump Financial increased its Fulcrum Therapeutics (FULC) stake by 301% in Q1 2026, buying an estimated $2.58M and bringing the position to 369,805 shares worth $2.84M. The position accounts for 0.04% of the portfolio, ranked #530.

Jump Financial first reported a position in FULC in Q2 2021 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Jump Financial held 369,805 shares of Fulcrum Therapeutics worth $2.84M as of Q1 2026.
  • Jump Financial bought 277,605 Fulcrum Therapeutics shares in Q1 2026, an estimated $2.58M.
  • Fulcrum Therapeutics made up 0.04% of Jump Financial's portfolio in Q1 2026, its #530 holding.
  • Jump Financial first reported a position in Fulcrum Therapeutics in Q2 2021 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.